Clinical Trials Logo

Stage IVB Colorectal Cancer clinical trials

View clinical trials related to Stage IVB Colorectal Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03800602 Active, not recruiting - Clinical trials for Colorectal Cancer Metastatic

Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer

Start date: January 15, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well nivolumab and metformin work in treating patients with microsatellite stable (MSS) stage IV colorectal cancer that has not responded to previous treatment. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Metformin is an antidiabetic drug that and may reduce the risk of colorectal cancer development in patients. Giving nivolumab and metformin may work better in treating patients with refractory microsatellite metastatic colorectal cancer.

NCT ID: NCT03275974 Active, not recruiting - Clinical trials for Stage IV Colorectal Cancer

Glutamine PET Imaging Colorectal Cancer

Start date: April 27, 2021
Phase: Phase 1
Study type: Interventional

The clinical trial studies how well 11C-glutamine and 18F-FSPG positron emission tomography (PET) imaging works in detecting tumors in patients with metastatic colorectal cancer compared to standard imaging methods such as magnetic resonance imaging (MRI) or computed tomography (CT) scanning.